Photo of Mark R. Stone, MD

Mark R. Stone, MD

Areas of Focus: Blood Disorders, Cancer, Cancer Chemotherapy
Accepting New Patients
1000 North Providence Drive, Suite 310
Newberg, OR 97132
815.2 miles away
Medical Groups & Affiliations
Providence Medical Group - Oregon
Speaks: English
map

Providence Cancer Institute - Newberg

1000 North Providence Drive, Suite 310, Newberg, OR 97132

Insurances Accepted

This information provides an overview of accepted insurance plan types for new patients. Coverage may vary by specific plan. Please verify with your insurance provider before visiting us for care. Established patients should call to verify insurance acceptance.

About Mark R. Stone

Dr. Mark Stone is a general hematologist and oncologist. He has extensive experience providing care for patients with a wide variety of cancer types and blood disorders. In his practice, Dr. Stone understands that communication with his patients is a vital aspect of his role as a physician. He is motivated to help his patients thrive.

Medical School

University of California, Irvine, School of Medicine
1996

Fellowship

University of California, San Diego School of Medicine
Hematology/Oncology
2003

Residency

University of California (San Diego) Medical Center
Internal Medicine
1999

Board Certifications
  • American Board of Internal Medicine, Hematology
  • American Board of Internal Medicine, Medical Oncology
Providence Cancer Institute - Newberg
1000 North Providence Drive, Suite 310
Newberg, OR 97132

Medical Groups & Affiliations
Providence Medical Group - Oregon

Affiliated Locations
Providence Newberg Medical Center

Conditions and Procedures

  • Anal Cancer
  • Anorectal Cancer
  • Atypical Ductal Hyperplasia
  • Bladder Cancer
  • Blood Cancer
  • Blood Disorders
  • Breast Cancer
  • Breast Lump
  • Cancer
  • Cancer Chemotherapy
  • Cancer During Pregnancy
  • Cancer Genomics
  • Cancer Pain
  • Cancer Risk Assessment
  • Cancer Survivor
  • Carcinoid Tumor
  • Carcinoma In Situ Of Breast
  • Carcinoma Of Unknown Primary
  • Chemoradiation
  • Chest Wall Tumors
  • Clinical Trials
  • Colon Cancer
  • Colorectal Cancer
  • Crizotinib
  • Ductal Carcinoma In Situ (Dcis)
  • Egfr Mutation
  • Egfr Translocation
  • Endocrine Complications Of Cancer Therapy
  • Erlotinib
  • Esophageal Cancer
  • Gastrointestinal (Gi) Cancer
  • Head And Neck Cancer
  • Hematologic Malignancies
  • Hemochromatosis
  • Leukocytosis
  • Leukopenia
  • Lobular Carcinoma In Situ (Lcis)
  • Lung Cancer
  • Lung Mass
  • Lung Metastasis
  • Lymphedema Therapy
  • Lymphoma
  • Male Breast Cancer
  • Mediastinal Mass
  • Melanoma
  • Mesothelioma
  • Metastatic Breast Cancer
  • Metastatic Liver Cancer
  • Metastatic Tumors To The Lungs
  • Multiple Myeloma
  • Non Hodgkin Lymphoma
  • Non Small Cell Lung Cancer
  • Oral Complications Of Cancer
  • Oral Lesions
  • Pancreas Cancer
  • Plasma Cell Dyscrasia
  • Polycythemia
  • Primary Myelofibrosis
  • Prostate Cancer
  • Pulmonary Metastases
  • Recurrent Colorectal Cancer
  • Sickle Cell Disease
  • Side Effects Of Cancer Treatment
  • Small Cell Lung Cancer
  • Stomach Cancer
  • Targeted Molecular Therapy
  • Thoracic Cancer
  • Thrombocytopenia
  • Unknown Primary Cancer
  • Virtual Care